New radiation therapy delays brain cancer regrowth, protects healthy tissue

by Jeanna Vazquez,University of California - San DiegoEach therapeutic seed, approximately the size of a postage stamp, contains radiation sources embedded in a collagen tile that together deliv

Updated on: January 11,2024 10

New radiation therapy delays brain cancer regrowth, protects healthy tissue

by Jeanna Vazquez,University of California - San DiegoEach therapeutic seed, approximately the size of a postage stamp, contains radiation sources embedded in a collagen tile that together deliv

Updated on:January 11,2024 10

New blood test for noncoding RNA significantly improves cancer detection

byUniversity of California - Santa CruzCell-free RNA transcriptome profiling using repeat-aware COMPLETE-seq.a, Diagram of COMPLETE-seq RNA liquid-biopsy technology, highlighting the use o

Updated on: January 11,2024 9

New blood test for noncoding RNA significantly improves cancer detection

byUniversity of California - Santa CruzCell-free RNA transcriptome profiling using repeat-aware COMPLETE-seq.a, Diagram of COMPLETE-seq RNA liquid-biopsy technology, highlighting the use o

Updated on:January 11,2024 9

Breast cancer spread uncovered by new molecular microscopy

byWellcome Trust Sanger InstituteConverting BaSISS spatial signals into maps of clones.a, Bar plots of cancer cell fractions (CCFs) derived from bulk WGS of the P1 samples.b, P

Updated on: January 11,2024 10

Breast cancer spread uncovered by new molecular microscopy

byWellcome Trust Sanger InstituteConverting BaSISS spatial signals into maps of clones.a, Bar plots of cancer cell fractions (CCFs) derived from bulk WGS of the P1 samples.b, P

Updated on:January 11,2024 10

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

Updated on: January 11,2024 10

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

Updated on:January 11,2024 10

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on: January 11,2024 15

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on:January 11,2024 15

New machine-learning method may aid personalized cancer therapy

byJohns Hopkins University School of MedicineExperimental procedure. The procedure includes presentation training, immunogenicity transfer learning and independent evaluation on multiple dataset

Updated on: January 11,2024 15

New machine-learning method may aid personalized cancer therapy

byJohns Hopkins University School of MedicineExperimental procedure. The procedure includes presentation training, immunogenicity transfer learning and independent evaluation on multiple dataset

Updated on:January 11,2024 15

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on: January 11,2024 15

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on:January 11,2024 15

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on: January 11,2024 15

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on:January 11,2024 15

New genetic study reveals why some women get aggressive breast and ovarian cancer

byUniversity of BergenIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) an

Updated on: January 12,2024 16

New genetic study reveals why some women get aggressive breast and ovarian cancer

byUniversity of BergenIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) an

Updated on:January 12,2024 16

New AI-based biomarker can help predict immunotherapy response for patients with lung cancer

byEmory UniversityResponder tumor to ICI has less tortuous vessel branches compared to nonresponder. (A and B) CT scans of a responder and nonresponder to IO with corresponding 3D rendering of t

Updated on: January 12,2024 9

New AI-based biomarker can help predict immunotherapy response for patients with lung cancer

byEmory UniversityResponder tumor to ICI has less tortuous vessel branches compared to nonresponder. (A and B) CT scans of a responder and nonresponder to IO with corresponding 3D rendering of t

Updated on:January 12,2024 9

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

Updated on: January 12,2024 10

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

Updated on:January 12,2024 10

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on: January 12,2024 10

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on:January 12,2024 10